Outsourcing Cytotoxic Drug Development?

Although regulatory requirements are fundamentally the same for all investigational drugs, working with cytotoxic materials presents unique challenges. Heightened safety procedures and encumbering personal protective equipment can be a drag on timelines—or worse, lead to procedural or analytical errors that compromise data integrity. It’s critical to choose a CRO with cytotoxic expertise, yet the field of competent outsourcing partners is small.

ABC understands that there are a myriad of practical business issues to consider when devising a development strategy. By applying our vast analytical expertise and in-depth knowledge of drug development requirements, we can help you balance risk with practical economics, ensuring optimal study design for your development objectives.